Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Related Citations for PubMed (Select 22072050)


Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study.

Sawka AM, Straus S, Gafni A, Meiyappan S, David D, Rodin G, Brierley JD, Tsang RW, Thabane L, Rotstein L, Ezzat S, Goldstein DP.

Support Care Cancer. 2012 Mar;20(3):641-5. doi: 10.1007/s00520-011-1302-x. Epub 2011 Nov 10.


Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Sawka AM, Straus S, Brierley JD, Tsang RW, Rotstein L, Rodin G, Gafni A, Ezzat S, Thabane L, Thorpe KE, Goldstein DP.

Trials. 2010 Jul 26;11:81. doi: 10.1186/1745-6215-11-81.


A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment.

Sawka AM, Straus S, Gafni A, Meiyappan S, O'Brien MA, Brierley JD, Tsang RW, Rotstein L, Thabane L, Rodin G, George SR, Goldstein DP.

Patient Educ Couns. 2011 Aug;84(2):e24-7. doi: 10.1016/j.pec.2010.07.038. Epub 2010 Aug 21.


Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer.

Sawka AM, Straus S, Rotstein L, Brierley JD, Tsang RW, Asa S, Segal P, Kelly C, Zahedi A, Freeman J, Solomon P, Anderson J, Thorpe KE, Gafni A, Rodin G, Goldstein DP.

J Clin Oncol. 2012 Aug 10;30(23):2906-11. doi: 10.1200/JCO.2011.41.2734. Epub 2012 Jul 2.


How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

Sawka AM, Straus S, Gafni A, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Thabane L, Rodin G, Meiyappan S, David D, Goldstein DP.

Clin Endocrinol (Oxf). 2011 Apr;74(4):419-23. doi: 10.1111/j.1365-2265.2010.03966.x.


The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.

Sawka AM, Rilkoff H, Tsang RW, Brierley JD, Rotstein L, Ezzat S, Asa SL, Segal P, Kelly C, Zahedi A, Gafni A, Goldstein DP.

Thyroid. 2013 Feb;23(2):246-7. doi: 10.1089/thy.2012.0422. No abstract available.


Patients' regrets after participating in a randomized controlled trials depended on their involvement in the decision making.

Mancini J, Genre D, Dalenc F, Ferrero JM, Kerbrat P, Martin AL, Roché H, Maylevin F, Tarpin C, Viens P, Gamet C, Julian-Reynier C.

J Clin Epidemiol. 2012 Jun;65(6):635-42. doi: 10.1016/j.jclinepi.2011.12.003. Epub 2012 Mar 19.


The relationship between extent of thyroid cancer surgery and use of radioactive iodine.

Haymart MR, Banerjee M, Yang D, Stewart AK, Doherty GM, Koenig RJ, Griggs JJ.

Ann Surg. 2013 Aug;258(2):354-8. doi: 10.1097/SLA.0b013e31826c8915.


Factors that influence radioactive iodine use for thyroid cancer.

Papaleontiou M, Banerjee M, Yang D, Sisson JC, Koenig RJ, Haymart MR.

Thyroid. 2013 Feb;23(2):219-24. doi: 10.1089/thy.2012.0380.


Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.

Chen PV, Osborne R, Ahn E, Avitia S, Juillard G.

Ear Nose Throat J. 2009 Jul;88(7):E01.


Illness perception in patients with differentiated epithelial cell thyroid cancer.

Hirsch D, Ginat M, Levy S, Benbassat C, Weinstein R, Tsvetov G, Singer J, Shraga-Slutzky I, Grozinski-Glasberg S, Mansiterski Y, Shimon I, Reicher-Atir R.

Thyroid. 2009 May;19(5):459-65. doi: 10.1089/thy.2008.0360.


The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.

Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Straus S, George SR, Abbey S, Rodin G, O'Brien MA, Gafni A, Thabane L, Goguen J, Naeem A, Magalhaes L.

PLoS One. 2009;4(1):e4191. doi: 10.1371/journal.pone.0004191. Epub 2009 Jan 14.


Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).

Farahati J, Reiners C, Stuschke M, Müller SP, Stüben G, Sauerwein W, Sack H.

Cancer. 1996 Jan 1;77(1):172-80.


Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.

Sawka AM, Goldstein DP, Thabane L, Brierley JD, Tsang RW, Rotstein L, Kamalanathan S, Zhao B, Gafni A, Straus S, Ezzat S.

Endocr Pract. 2008 Mar;14(2):175-84.


Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.

Sawka AM, Rotstein L, Brierley JD, Tsang RW, Thabane L, Gafni A, Straus S, Kamalanathan S, Zhao B, Goldstein DP, Rambaldini G, Ezzat S.

Thyroid. 2007 Dec;17(12):1235-42.


Satisfaction with treatment decision-making and treatment regret among Latinas and non-Latina whites with DCIS.

López ME, Kaplan CP, Nápoles AM, Hwang ES, Livaudais JC, Karliner LS.

Patient Educ Couns. 2014 Jan;94(1):83-9. doi: 10.1016/j.pec.2013.09.005. Epub 2013 Sep 17.


Radioactive iodine treatment in medullary thyroid carcinoma.

Faik Erdogan M, Gursoy A, Erdogan G, Kamel N.

Nucl Med Commun. 2006 Apr;27(4):359-62.


Low-risk papillary thyroid cancer recurrence in patients treated with total thyroidectomy and adjuvant therapy vs. patients treated with partial thyroidectomy.

Hurtado-López LM, Melchor-Ruan J, Basurto-Kuba E, Montes de Oca-Durán ER, Pulido-Cejudo A, Athié-Gutiérrez C.

Cir Cir. 2011 Mar-Apr;79(2):118-25.


Racial and ethnic variation in partner perspectives about the breast cancer treatment decision-making experience.

Lillie SE, Janz NK, Friese CR, Graff JJ, Schwartz K, Hamilton AS, Gay BB, Katz SJ, Hawley ST.

Oncol Nurs Forum. 2014 Jan 1;41(1):13-20. doi: 10.1188/14.ONF.13-20.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk